PUBLISHER: Renub Research | PRODUCT CODE: 1484130
PUBLISHER: Renub Research | PRODUCT CODE: 1484130
Photodynamic Therapy Market Report by Product Types, Application, End-User, Countries and Company Analysis 2024- 2032
Global Photodynamic Therapy Market was worth US$ 3.63 Billion in 2023. Renub Research forecasts a 7.52% CAGR from 2024 to 2032. The market is projected to be valued at US$ 6.97 Billion by 2032.
A medication called a photosensitizer is combined with light energy in a two-stage treatment called photodynamic therapy (PDT), which is intended to kill malignant and precancerous cells upon light activation. Photosensitive materials are activated by specific light wavelengths, commonly released by lasers. The photosensitizer is safe until light causes it to become active. On the other hand, the photosensitizer becomes poisonous to the targeted tissue upon light activation. Today, there are many photosensitizer medications available to treat a wide range of conditions, such as age-related macular degeneration, acne, psoriasis, and numerous malignancies of the skin, lungs, brain, esophagus, bile duct, pancreas, bladder, and head and neck. PDT aids in treating bacterial, fungal, and viral infections in addition to these ailments.
Global Photodynamic Therapy Market Trends
- Increasing Cancer incidence and broader Usage
The estimates from IARC's Global Cancer Observatory in 2022 revealed that ten types of cancer accounted for two-thirds of global new instances and deaths. Lung cancers led with 2.5 Million new instances, comprising 12.4% of new cases. Photodynamic therapy emerges as a versatile remedy beyond oncology as cancer rates surge. Initially, for cancers, PDT now reveals utility in age-associated macular degeneration management. The BMC Ophthalmology estimates a prevalence of 10.8% in males and 9.8% in women. PDT also shows promise in treating acne vulgaris and psoriasis. This drives the global photodynamic therapy market boom through expanded investments and research.
- Approvals from Clinical Trials
Clinical approvals are pivotal for the global photodynamic therapy market, expanding its applications past oncology. As regulatory bodies greenlight PDT for numerous medical situations, confidence in its efficacy grows. These approvals propel the demand for PDT, fueling investment in studies and improvement to enhance its accessibility and effectiveness. Consequently, clinical approvals catalyze the PDT market, facilitating its adoption in mainstream clinical practice and fostering growth. For instance, in July 2023, the FDA specified the orphan drug padeliporfin VTP as a potential healing alternative in domestically advanced pancreatic cancer patients.
- Increase in Healthcare Expenditure on a Global Scale
Healthcare spending worldwide is growing, creating substantial possibilities for photodynamic therapy and other superior treatments. The World Health Organization's report in 2023 documented global health spending hitting a record $9.8 trillion in 2021, making up 10.3% of the sector's general income. Governments and corporations are spending more on healthcare, particularly for new and better ways to deal with complicated ailments. PDT is one such way. It is regarded capable of treating many distinct concerns and has appropriate results. More cash going into healthcare gives extra chances for PDT to grow and become familiar with dealing with ailments, boosting the photodynamic therapy market.
United States Photodynamic Therapy Market
United States photodynamic therapy market is seen as a promising part of the worldwide market. It is mainly valued for its success in treating skin cancer. This is because skin cancer rates are going up, and more individuals understand how powerful PDT can be. According to Cancer.Net, about 97,610 adults in the US had been recognized with invasive melanoma of the skin in 2023. At the same time, technological improvements, similar to what's taking place around the sector, are making the US market even more potent. New photosensitizer traits and light delivery structures make PDT work better for many exclusive uses.
Medicare coverage for specific PDT procedures in the United States also aids in market expansion by improving patient access and affordability. The Centers for Medicare & Medicaid Services (CMS) are extending coverage to ocular photodynamic therapy (OPT) with verteporfin for "wet" age-related macular edema (AMD). Follow-up treatments require fluorescein angiography (FA) testing for coverage. The growing elderly population in the US also reflects global demographics. This offers chances for PDT use in managing age-related macular degeneration, which is especially critical among seniors.
Global Photodynamic Therapy Company News
Gladerma S.A., Sun Pharmaceutical Industries Ltd., Biofrontera Inc., Lumibird S.A., Bausch Health Companies Inc., Soligenix Inc., Modulight Corporation, and Theralase Technologies Inc. are the leading companies in the global photodynamic therapy market.
- In January 2023 - Biofrontera AG disclosed that its subsidiary, Biofrontera Bioscience GmbH, was granted a notice of allowance for the patent application "Photodynamic therapy comprising two light exposures at different wavelengths" by the US Patent and Trademark Office (USPTO). The patent safeguards several advancements concerning a novel illumination technique for treating dermatological skin conditions with Photodynamic Therapy (PDT).
- In February 2023 - Bausch + Lomb Corporation and Modulight Corporation revealed FDA approval for the ML6710i photodynamic laser. It's cleared for use alongside Bausch + Lomb's VISUDYNE (verteporfin for injection) photodynamic therapy (PDT) to treat patients with predominantly classic subfoveal choroidal neovascularization, a complication of Age-related Macular Degeneration (AMD).
- In May 2023 - Rakuten Medical received approval from the Indian Central Drugs Standard Control Organization (CDSCO) to conduct its global Phase III clinical trial on Alluminox treatment (photoimmunotherapy) with ASP-1929 for patients with locoregional, recurrent head and neck squamous cell carcinomas (HNSCC) in India.
- In August 2023 - ImPact Biotech, a leader in photodynamic therapy, partnered with Maastricht University to research treating Pathological Myopia, also known as Myopic Macular Degeneration (MMD). They will utilize ImPact's Padeliporfin Vascular targeted photodynamic therapy (VTP) platform.
- In July 2022 - Biolitec Pharma Ltd. unveiled the ELVeS Radial Laser System, its latest-generation laser device. This innovation expands treatment options for cancer, benign prostatic hyperplasia, and varicose veins, demonstrating ongoing advancements in photodynamic therapy technologies.
- In June 2022 - DUSA Pharmaceuticals launched Levulan(R) (aminolevulinic acid HCl), a new photodynamic therapy product for treating actinic keratosis. It improves comfort and enhances patient experience, advancing photodynamic therapy in dermatology.
Product types - Market breakup in 2 viewpoints:
1. Photodynamic Therapy Devices
2. Photosensitizer Drugs
Application - Market breakup in 5 viewpoints:
1. Cancer
2. Actinic Keratosis
3. Psoriasis
4. Acne
5. Others
End-User - Market breakup in 4 viewpoints:
1. Hospitals
2. Cosmetics & Dermatology Clinics
3. Cancer Treatment Centers
4. Others
Country - Market breakup of 25 Countries:
1. North America
- 1.1 United States
- 1.2 Canada
2. Europe
- 2.1 France
- 2.2 Germany
- 2.3 Italy
- 2.4 Spain
- 2.5 United Kingdom
- 2.6 Belgium
- 2.7 Netherlands
- 2.8 Turkey
3. Asia Pacific
- 3.1 China
- 3.2 Japan
- 3.3 India
- 3.4 South Korea
- 3.5 Thailand
- 3.6 Malaysia
- 3.7 Indonesia
- 3.8 Australia
- 3.9 New Zealand
4. Latin America
- 4.1 Brazil
- 4.2 Mexico
- 4.3 Argentina
5. Middle East & Africa
- 5.1 Saudi Arabia
- 5.2 UAE
- 5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Gladerma S.A.
2. Sun Pharmaceutical Industries Ltd.
3. Biofrontera Inc.
4. Lumibird S.A.
5. Bausch Health Companies Inc.
6. Soligenix Inc.
7. Modulight Corporation
8. Theralase Technologies Inc.
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Global Photodynamic Therapy Market
6. Global Photodynamic Therapy - Market Share Analysis
- 6.1 By Product Type
- 6.2 By Application
- 6.3 By End User
- 6.4 By Countries
7. Product Type - Global Photodynamic Therapy Market
- 7.1 Photodynamic Therapy Devices
- 7.2 Photosensitizer Drugs
8. Application - Global Photodynamic Therapy Market
- 8.1 Cancer
- 8.2 Actinic Keratosis
- 8.3 Psoriasis
- 8.4 Acne
- 8.5 Others
9. End User - Global Photodynamic Therapy Market
- 9.1 Hospitals
- 9.2 Cosmetics & Dermatology Clinics
- 9.3 Cancer Treatment Centers
- 9.4 Others
10. Countries - Global Photodynamic Therapy Market
- 10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.2 Europe
- 10.2.1 France
- 10.2.2 Germany
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Belgium
- 10.2.7 Netherland
- 10.2.8 Turkey
- 10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Thailand
- 10.3.6 Malaysia
- 10.3.7 Indonesia
- 10.3.8 Australia
- 10.3.9 New Zealand
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.2 Mexico
- 10.4.3 Argentina
- 10.5 Middle East & Africa
- 10.5.1 Saudi Arabia
- 10.5.2 UAE
- 10.5.3 South Africa
11. Porter's Five Forces Analysis - Global Photodynamic Therapy Market
- 11.1 Bargaining Power of Buyers
- 11.2 Bargaining Power of Suppliers
- 11.3 Degree of Rivalry
- 11.4 Threat of New Entrants
- 11.5 Threat of Substitutes
12. SWOT Analysis - Global Photodynamic Therapy Market
- 12.1 Strength
- 12.2 Weakness
- 12.3 Opportunity
- 12.4 Threat
13. Key Players Analysis
- 13.1 Gladerma S.A
- 13.1.1 Overview
- 13.1.2 Recent Development
- 13.1.3 Revenue Analysis
- 13.2 Sun Pharmaceutical Industries Ltd
- 13.2.1 Overview
- 13.2.2 Recent Development
- 13.2.3 Revenue Analysis
- 13.3 Biofrontera Inc.
- 13.3.1 Overview
- 13.3.2 Recent Development
- 13.3.3 Revenue Analysis
- 13.4 Lumibird S.A
- 13.4.1 Overview
- 13.4.2 Recent Development
- 13.4.3 Revenue Analysis
- 13.5 Bausch Health Companies Inc.
- 13.5.1 Overview
- 13.5.2 Recent Development
- 13.5.3 Revenue Analysis
- 13.6 Soligenix Inc.
- 13.6.1 Overview
- 13.6.2 Recent Development
- 13.6.3 Revenue Analysis
- 13.7 Modulight Corporation
- 13.7.1 Overview
- 13.7.2 Recent Development
- 13.7.3 Revenue Analysis
- 13.8 Theralase Technologies Inc.
- 13.8.1 Overview
- 13.8.2 Recent Development
- 13.8.3 Revenue Analysis
List of Figures
- Figure-01: Global - Photodynamic Therapy Market (Billion US$), 2019 - 2023
- Figure-02: Global - Forecast for Photodynamic Therapy Market (Billion US$), 2024 - 2032
- Figure-03: Product Type - Photodynamic Therapy Devices Market (Million US$), 2019 - 2023
- Figure-04: Product Type - Forecast for Photodynamic Therapy Devices Market (Million US$), 2024 - 2032
- Figure-05: Product Type - Photosensitizer Drugs Market (Million US$), 2019 - 2023
- Figure-06: Product Type - Forecast for Photosensitizer Drugs Market (Million US$), 2024 - 2032
- Figure-07: Application - Cancer Market (Million US$), 2019 - 2023
- Figure-08: Application - Forecast for Cancer Market (Million US$), 2024 - 2032
- Figure-09: Application - Actinic Keratosis Market (Million US$), 2019 - 2023
- Figure-10: Application - Forecast for Actinic Keratosis Market (Million US$), 2024 - 2032
- Figure-11: Application - Psoriasis Market (Million US$), 2019 - 2023
- Figure-12: Application - Forecast for Psoriasis Market (Million US$), 2024 - 2032
- Figure-13: Application - Acne Market (Million US$), 2019 - 2023
- Figure-14: Application - Forecast for Acne Market (Million US$), 2024 - 2032
- Figure-15: Application - Others Market (Million US$), 2019 - 2023
- Figure-16: Application - Forecast for Others Market (Million US$), 2024 - 2032
- Figure-17: End User - Hospitals Market (Million US$), 2019 - 2023
- Figure-18: End User - Forecast for Hospitals Market (Million US$), 2024 - 2032
- Figure-19: End User - Cosmetics & Dermatology Clinics Market (Million US$), 2019 - 2023
- Figure-20: End User - Forecast for Cosmetics & Dermatology Clinics Market (Million US$), 2024 - 2032
- Figure-21: End User - Cancer Treatment Centers Market (Million US$), 2019 - 2023
- Figure-22: End User - Forecast for Cancer Treatment Centers Market (Million US$), 2024 - 2032
- Figure-23: End User - Others Market (Million US$), 2019 - 2023
- Figure-24: End User - Forecast for Others Market (Million US$), 2024 - 2032
- Figure-25: United States - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-26: United States - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-27: Canada - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-28: Canada - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-29: France - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-30: France - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-31: Germany - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-32: Germany - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-33: Italy - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-34: Italy - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-35: Spain - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-36: Spain - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-37: United Kingdom - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-38: United Kingdom - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-39: Belgium - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-40: Belgium - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-41: Netherland - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-42: Netherland - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-43: Turkey - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-44: Turkey - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-45: China - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-46: China - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-47: Japan - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-48: Japan - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-49: India - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-50: India - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-51: South Korea - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-52: South Korea - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-53: Thailand - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-54: Thailand - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-55: Malaysia - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-56: Malaysia - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-57: Indonesia - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-58: Indonesia - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-59: Australia - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-60: Australia - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-61: New Zealand - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-62: New Zealand - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-63: Brazil - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-64: Brazil - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-65: Mexico - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-66: Mexico - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-67: Argentina - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-68: Argentina - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-69: Saudi Arabia - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-70: Saudi Arabia - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-71: UAE - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-72: UAE - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-73: South Africa - Photodynamic Therapy Market (Million US$), 2019 - 2023
- Figure-74: South Africa - Forecast for Photodynamic Therapy Market (Million US$), 2024 - 2032
- Figure-75: Gladerma S.A - Global Revenue (Million US$), 2019 - 2023
- Figure-76: Gladerma S.A - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-77: Sun Pharmaceutical Industries Ltd - Global Revenue (Million US$), 2019 - 2023
- Figure-78: Sun Pharmaceutical Industries Ltd - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-79: Biofrontera Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-80: Biofrontera Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-81: Lumibird S.A - Global Revenue (Million US$), 2019 - 2023
- Figure-82: Lumibird S.A - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-83: Bausch Health Companies Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-84: Bausch Health Companies Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-85: Soligenix Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-86: Soligenix Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-87: Modulight Corporation - Global Revenue (Million US$), 2019 - 2023
- Figure-88: Modulight Corporation - Forecast for Global Revenue (Million US$), 2024 - 2032
- Figure-89: Theralase Technologies Inc. - Global Revenue (Million US$), 2019 - 2023
- Figure-90: Theralase Technologies Inc. - Forecast for Global Revenue (Million US$), 2024 - 2032
List of Tables
- Table-01: Global - Photodynamic Therapy Market Share by Product Type (Percent), 2019 - 2023
- Table-02: Global - Forecast for Photodynamic Therapy Market Share by Product Type (Percent), 2024 - 2032
- Table-03: Global - Photodynamic Therapy Market Share by Application (Percent), 2019 - 2023
- Table-04: Global - Forecast for Photodynamic Therapy Market Share by Application (Percent), 2024 - 2032
- Table-05: Global - Photodynamic Therapy Market Share by End Use (Percent), 2019 - 2023
- Table-06: Global - Forecast for Photodynamic Therapy Market Share by End Use (Percent), 2024 - 2032
- Table-07: Global - Photodynamic Therapy Market Share by Countries (Percent), 2019 - 2023
- Table-08: Global - Forecast for Photodynamic Therapy Market Share by Countries (Percent), 2024 - 2032
